CareDx, Inc.
CDNA · XNASCIK 1217234fmd_07H2CD9A40497FK38XRSYMYEM4Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2012 to Sep 30, 2026, 56 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 41 | 48 | 77 | 127 | 192 | 296 | 322 | 280 | 334 | 380 |
| Cost of revenue | 10 | 21 | 33 | 45 | – | – | – | – | – | – |
| Net interest income | (2) | – | – | – | – | – | – | – | – | – |
| Gross profit | 30 | 27 | 44 | 82 | – | – | – | – | – | – |
| Realized investment gains (losses) | – | – | – | – | – | 0 | 0 | 2 | 0 | 0 |
| Research and development | 12 | 12 | 15 | 31 | 49 | 77 | 90 | 82 | 73 | 71 |
| Selling, general and administrative | 32 | 33 | 45 | 75 | 103 | 152 | 196 | 203 | 207 | 210 |
| Total operating expenses | 78 | 47 | 92 | 152 | 215 | 326 | 399 | 484 | 293 | 411 |
| Operating income | (37) | (20) | (16) | (25) | (23) | (30) | (77) | (203) | 41 | (31) |
| Interest expense | – | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (2) | (37) | (33) | 1 | 3 | (2) | 1 | 13 | 12 | 10 |
| Income before taxes | (41) | (57) | (48) | (24) | (20) | (32) | (76) | (190) | 53 | (21) |
| Income tax expense | (2) | (2) | (1) | (2) | (1) | (1) | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (40) | (56) | (47) | (22) | (19) | (31) | (77) | (190) | 53 | (21) |
| Net income | (39) | (55) | (47) | (22) | (19) | (31) | (77) | (190) | 53 | (21) |
| Net income to common shareholders | (39) | (55) | (47) | (22) | (19) | (31) | (77) | (190) | 53 | (21) |